GLP-1 Weight Loss Drugs: Why Ozempic Remains the Leading Choice
Positioning Ozempic in the Landscape of GLP-1 Weight Loss Medications As obesity and metabolic disorders continue to surge globally, the therapeutic landscape has witnessed a paradigm shift with the advent of glucagon-like peptide-1 (GLP-1) receptor agonists. Among these, Ozempic (semaglutide) has emerged as the preeminent choice, not merely due to its efficacy but because of … Read more